This is unpublished
News

FDA Lifts Ban on Sending Mifepristone by Mail

January 27, 2022
Pinned
Back to top

Dr. Emily Godfrey, Associate Professor of ObGyn, was recently quoted in a Prevention article about the recent FDA decision to lift its existing ban on sending Mifepristone in the mail. Dr. Godfrey stated “Mifepristone is a really important medication not only for people who are seeking pregnancy termination, but also for people who are seeking miscarriage management.”. Read the article at this link.

News Categories

Recent News

1 month ago
The Department of ObGyn celebrates World Menopause Day with…
1 month 1 week ago
The Department of OBGYN celebrates Indigenous Peoples'…
4 months 1 week ago
16 Faculty Recognized in Seattle Magazine Top Doctors 2022
seattle mag